Postes actifs de Dennis J. Church
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Xigen SA
 Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Corporate Officer/Principal | 17/11/2009 | - |
Historique de carrière de Dennis J. Church
Anciens postes connus de Dennis J. Church
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Suisse | 3 |
Opérationnelle
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Xigen SA
Xigen SA Pharmaceuticals: MajorHealth Technology Xigen SA develops intracellular peptide therapeutics for the treatment of stroke, myocardial infarction and cancer. It focuses on the acute or short-term treatment of major debilitating pathologies that underly unmet medical needs plaguing humanity. The company was founded in 2002 and is headquartered in Epalinges, Switzerland. | Health Technology |
| Glaxo-Welcomes' Research Institute |
- Bourse
- Insiders
- Dennis J. Church
- Expérience
